翰森制药:39亿融资背后

药事纵横
Aug 25, 2025

近日,翰森制药一则配售融资公告引发市场热议。这家手握271亿元现金、半年盈利超31亿元的药企巨头,选择在股价高位折让配售,募资39亿港元。表面看,这与公司充裕的现金流形成鲜明对比;深层次看,这反映了创新药研发的巨额投入与资本市场波动之间的深刻矛盾。业绩亮眼却融资翰森制药2025年上半年的业绩表现格外亮眼。其总收入约达74.34亿元,与去年同期相比增长了14.3%;溢利约为31.35亿元,同比增长...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10